Trafficking of Dendritic Cells

Leukocyte Trafficking: Molecular Mechanisms, Therapeutic Targets, and Methods

Volumn , Issue , 2006, Pages 184-215

  Romani, Nikolaus ^a   Holzmann, Sandra ^a   Tripp, Christoph H ^a   Sixt, Michael ^b   Stoitzner, Patrizia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Dendritic cell trafficking; Functional implications; Leukocyte trafficking; Morphology; Pathways; Regulation of dendritic cell trafficking; Trafficking in vivo; Trafficking of dendritic cells

Indexed keywords

EID: 84889417561     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/352760779X.ch10     Document Type: Chapter

References (178)

1. Romani, N., S. Turley, M. Pypaert, M. Ebersold, I. Mellman, G. Schuler, and R.M. Steinman. 2003. Dendritic cells. In Atlas of Blood Cells-Function and Pathology. D. Zucker-Franklin and C.E. Grossi, editors. Ermes, Milan. 449-478.
2. Steinkasserer, A., N. Romani, and M.B. Lutz, eds. 2005. Dendritic Cells. Wiley-VCH, Weinheim (in press).
3. Heath, W.R., G.T. Belz, G.M. Behrens, C.M. Smith, S.P. Forehan, I.A. Parish, G.M. Davey, N.S. Wilson, F.R. Carbone, and J. Villadangos. 2004. Crosspresentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199:9-26.
4. Steinman, R.M., D. Hawiger, and M.C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
5. Romani, N., S. Holzmann, C.H. Tripp, F. Koch, and P. Stoitzner. 2003. Langerhans cells-dendritic cells of the epidermis. APMIS 111:725-740.
6. Wolff, K. 1967. The fine structure of the Langerhans cell granule. J. Cell. Biol. 35:468-473.
7. Valladeau, J., C. Dezutter-Dambuyant, and S. Saeland. 2003. Langerin/CD207 sheds light on formation of Birbeck granules and their possible function in Langerhans cells. Immunol. Res. 28:93-107.
8. Kraal, G., M. Breel, M. Janse, and G. Bruin. 1986. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163:981-997.
9. Ebner, S., Z. Ehammer, S. Holzmann, P. Schwingshackl, M. Forstner, P. Stoitzner, G.M. Huemer, P. Fritsch, and N. Romani. 2004. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int. Immunol. 16:877-887.
10. Mahnke, K., M. Guo, S. Lee, H. Sepulveda, S.L. Swain, M. Nussenzweig, and R.M. Steinman. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:673-683.
11. Bonifaz, L.C., D.P. Bonnyay, A. Charalambous, D.I. Darguste, S.I. Fujii, H. Soares, M.K. Brimnes, B. Moltedo, T.M. Moran, and R.M. Steinman. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815-824.
12. Hawiger, D., R.F. Masilamani, E. Betteli, V.K. Kuchroo, and M.C. Nussenzweig. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20:695-705.
13. Schuler, G. and R.M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526-546.
14. Fujii, S., K. Liu, C. Smith, A.J. Bonito, and R.M. Steinman. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607-1618.
15. Romani, N., G. Ratzinger, K. Pfaller, W. Salvenmoser, H. Stössel, F. Koch, and P. Stoitzner. 2001. Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. Int. Rev. Cytol. 207:237-270.
16. Robert, C., R.C. Fuhlbrigge, J.D. Kieffer, S. Ayehunie, R.O. Hynes, G.Y. Cheng, S. Grabbe, U.H. Von Andrian, and T.S. Kupper. 1999. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance. J. Exp. Med. 189:627-635.
17. Holzmann, S., C.H. Tripp, M. Schmuth, K. Janke, F. Koch, S. Saeland, P. Stoitzner, and N. Romani. 2004. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J. Invest. Dermatol. 122:1165-1174.
18. Chang-Rodriguez, S., W. Hoetzenecker, C. Schwärzler, T. Biedermann, S. Saeland, and A. Elbe-Bürger. 2005. Fetal and neonatal murine dendritic epidermal leukocytes are Langerhans cell precursors. J. Leukoc. Biol. 77:352-360.
19. Randolph, G.J., K. Inaba, D.F. Robbiani, R.M. Steinman, and W.A. Muller. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753-761.
20. Stoitzner, P., K. Pfaller, H. Stössel, and N. Romani. 2002. A close-up view of migrating Langerhans cells in the skin. J. Invest. Dermatol. 118:117-125.
21. Huang, F.P., N. Platt, M. Wykes, J.R. Major, T.J. Powell, C.D. Jenkins, and G.G. MacPherson. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435-443.
22. Hemmi, H., M. Yoshino, H. Yamazaki, M. Naito, T. Iyoda, Y. Omatsu, S. Shimoyama, J.J. Letterio, T. Nakabayashi, H. Tagaya, T. Yamane, M. Ogawa, S. Nishikawa, K. Ryoke, K. Inaba, S. Hayashi, and T. Kunisada. 2001. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-a1-dependent cells. Int. Immunol. 13:695-704.
23. Sugiura, K., M. Shamoto, N. Sakamoto, M. Shinzato, A. Osada, M. Sugiura, R. Hayakawa, and Y. Kato. 2003. It is true that, when Langerhans cells migrate from the skin to the lymph node, they are transported via lymph vessels. Dermatology 206:222-224.
24. Romani, N., A. Lenz, H. Glassel, H. Stössel, U. Stanzl, O. Majdic, P. Fritsch, and G. Schuler. 1989. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J. Invest. Dermatol. 93:600-609.
25. Weinlich, G., M. Heine, H. Stössel, M. Zanella, P. Stoitzner, U. Ortner, J. Smolle, F. Koch, N.T. Sepp, G. Schuler, and N. Romani. 1998. Entry into afferent lymphatics and maturation in situ of migrating cutaneous dendritic cells. J. Invest. Dermatol. 110:441-448.
26. Lukas, M., H. Stössel, L. Hefel, S. Imamura, P. Fritsch, N.T. Sepp, G. Schuler, and N. Romani. 1996. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 106:1293-1299.
27. Huang, A.Y.C., H. Qi, and R.N. Germain. 2004. Illuminating the landscape of in vivo immunity: insights from dynamic in situ imaging of secondary lymphoid tissues. Immunity 21:331-339.
28. Catron, D.M., A.A. Itano, K.A. Pape, D.L. Mueller, and M.K. Jenkins. 2004. Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity 21:341-347.
29. Sumen, C., T.R. Mempel, I.B. Mazo, and U.H. Von Andrian. 2004. Intravital microscopy: visualizing immunity in context. Immunity 21:315-329.
30. Bousso, P. and E.A. Robey. 2004. Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy. Immunity 21:349-345.
31. Engering, A., S.J. Van Vliet, K. Hebeda, D.G. Jackson, R. Prevo, S.K. Singh, T.B.H. Geijtenbeek, H. Van Krieken, and Y. Van Kooyk. 2004. Dynamic populations of dendritic cellspecific ICAM-3 grabbing nonintegrinpositive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am. J. Pathol. 164:1587-1595.
32. Van den Berg, T.K., J.J.P. Brevé, J.G.M.C. Damoiseaux, E.A. Döpp, S. Kelm, P.R. Crocker, C.D. Dijkstra, and G. Kraal. 1992. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J. Exp. Med. 176:647-655.
33. Katakai, T., T. Hara, J.H. Lee, H. Gonda, M. Sugai, and A. Shimizu. 2004. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int. Immunol. 16:1133-1142.
34. Ushiki, T., O. Ohtani, and K. Abe. 1995. Scanning electron microscopic studies of reticular framework in the rat mesenteric lymph node. Anat. Rec. 241:113-122.
35. Gretz, J.E., A.O. Anderson, and S. Shaw. 1997. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 156:11-24.
36. Pribila, J.T., A.C. Quale, K.L. Mueller, and Y. Shimizu. 2004. Integrins and T cell-mediated immunity. Annu. Rev. Immunol. 22:157-180.
37. Cyster, J.G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23:127-159.
38. Sixt, M., N. Kanazawa, M. Selg, T. Samson, G. Roos, D.P. Reinhardt, R. Pabst, M.B. Lutz, and L.M. Sorokin. 2005. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22:19-29.
39. Bajénoff, M., S. Granjeaud, and S. Guerder. 2003. The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. J. Exp. Med. 198:715-724.
40. Gunzer, M., A. Schäfer, S. Borgmann, S. Grabbe, K.S. Zänker, E.B. Bröcker, E. Kämpgen, and P. Friedl. 2000. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 13:323-332.
41. Miller, M.J., A.S. Hejazi, S.H. Wei, M.D. Cahalan, and I. Parker. 2004. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc. Natl. Acad. Sci. U. S. A. 101:998-1003.
42. Benvenuti, F., S. Hugues, M. Walmsley, S. Ruf, L. Fetler, M. Popoff, V.L.J. Tybulewicz, and S. Amigorena. 2004. Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science 305:1150-1153.
43. Mempel, T.R., S.E. Henrickson, and U.H. Von Andrian. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154-159.
44. Randolph, G.J., S. Beaulieu, S. Lebecque, R.M. Steinman, and W.A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480-483.
45. Geissmann, F., S. Jung, and D.R. Littman. 2004. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82.
46. Randolph, G.J., G. Sanchez-Schmitz, R.M. Liebman, and K. Schäkel. 2002. The CD16{thorn} (FcgammaRIII{thorn}) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196:517-527.
47. Randolph, G.J., G. Sanchez-Schmitz, and V. Angeli. 2004. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin. Immunopathol. 26:273-287.
48. Vicari, A.P., I. Treilleux, and S. Lebecque. 2004. Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines. Semin. Cancer Biol. 14:161-169.
49. Gunn, M.D. 2003. Chemokine mediated control of dendritic cell migration and function. Semin. Immunol. 15:271-276.
50. Caux, C., B. Vandervliet, C. Massacrier, S. Ait-Yahia, C. Vaure, K. Chemin, M.C. Dieu-Nosjean, and A. Vicari. 2002. Regulation of dendritic cell recruitment by chemokines. Transplantation 73:S7-S11.
51. Sallusto, F. and A. Lanzavecchia. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189:611-614.
52. Flores-Romo, L. 2001. In vivo maturation and migration of dendritic cells. Immunology 102:255-262.
53. Merad, M., M.G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I.L. Weissman, J.G. Cyster, and E.G. Engleman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3:1135-1141.
54. Kamath, A.T., S. Henri, F. Battye, D.F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100:1734-1741.
55. Romani, N., G. Schuler, and P.O. Fritsch. 1986. The ontogeny of Iapositive and Thy-1 positive leukocytes of murine epidermis. J. Invest. Dermatol. 86:129-133.
56. Elbe, A., E. Tschachler, G. Steiner, A. Binder, K. Wolff, and G. Stingl. 1989. Maturational steps of bone marrow-derived dendritic murine epidermal cells: phenotypic and functional studies on Langerhans cells and Thy-1{thorn} dendritic epidermal cells in the perinatal period. J. Immunol. 143:2431-2438.
57. Dewar, A.L., K.V. Doherty, G.M. Woods, A.B. Lyons, and H.K. Muller. 2001. Acquisition of immune function during the development of the Langerhans cell network in neonatal mice. Immunology 103:61-69.
58. Tripp, C.H., S. Chang-Rodriguez, P. Stoitzner, S. Holzmann, H. Stössel, P. Douillard, S. Saeland, F. Koch, A. Elbe-Bürger, and N. Romani. 2004. Ontogeny of Langerin/ CD207 expression in the epidermis of mice. J. Invest. Dermatol. 122:670-672.
59. Nguyen, V.A., S. Ebner, C. Fürhapter, N. Romani, D. Kölle, P. Fritsch, and N. Sepp. 2002. Adhesion of dendritic cells derived from CD34{thorn} progenitors to resting human dermal microvascular endothelial cells is down-regulated upon maturation and partially depends on CD11a-CD18, CD11b-CD18 and CD36. Eur. J. Immunol. 32:3638-3650.
60. Nguyen, V.A., M. Kirchmair, C. Fürhapter, N. Romani, and N. Sepp. 2004. Adhesive interactions between CD34{thorn}-derived dendritic cell precursors and dermal microvascular endothelial cells studied by scanning electron microscopy. Cell Tissue Res. 315:139-143.
61. Caux, C., B. Vanbervliet, C. Massacrier, C. Dezutter-Dambuyant, B. De Saint-Vis, C. Jacquet, K. Yoneda, S. Imamura, D. Schmitt, and J. Banchereau. 1996. CD34{thorn} hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GMCSF{thorn}TNFa. J. Exp. Med. 184:695-706.
62. Ito, T., M. Inaba, K. Inaba, J. Toki, S. Sogo, T. Iguchi, Y. Adachi, K. Yamaguchi, R. Amakawa, J. Valladeau, S. Saeland, S. Fukuhara, and S. Ikehara. 1999. A CD1a{thorn}/CD11c{thorn} subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 163:1409-1419.
63. Larregina, A.T., A.E. Morelli, L.A. Spencer, A.J. Logar, S.C. Watkins, A.W. Thomson, and L.D. Falo, Jr. 2001. Dermal-resident CD14{thorn} cells differentiate into Langerhans cells. Nat. Immunol. 2:1151-1158.
64. Dieu, M.C., B. Vanbervliet, A. Vicari, J.M. Bridon, E. Oldham, S. Aït-Yahia, F. Brière, A. Zlotnik, S. Lebecque, and C. Caux. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386.
65. Dieu-Nosjean, M.C., C. Massacrier, B. Homey, B. Vanbervliet, J.J. Pin, A. Vicari, S. Lebecque, C. Dezutter-Dambuyant, D. Schmitt, A. Zlotnik, and C. Caux. 2000. Macrophage inflammatory protein 3a is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192:705-717.
66. Charbonnier, A.S., N. Kohrgruber, E. Kriehuber, G. Stingl, A. Rot, and D. Maurer. 1999. Macrophage inflammatory protein 3a is involved in the constitutive trafficking of epidermal Langerhans cells. J. Exp. Med. 190:1755-1767.
67. Schmuth, M., S. Neyer, C. Rainer, A. Grassegger, P. Fritsch, N. Romani, and C. Heufler. 2002. Expression of the C-C chemokine MIP-3alpha/CCL20 in human epidermis with impaired permeability barrier function. Exp. Dermatol. 11:135-142.
68. Partida-Sánchez, S., S. Goodrich, K. Kusser, N. Oppenheimer, T.D. Randall, and F.E. Lund. 2004. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 20:279-291.
69. Vanbervliet, A., B. Homey, I. Durand, C. Massacrier, S. Aït-Yahia, O. de Bouteiller, A. Vicari, and C. Caux. 2002. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur. J. Immunol. 32:231-242.
70. Cook, D.N., D.M. Prosser, R. Förster, J. Zhang, N.A. Kuklin, S.J. Abbondanzo, X.D. Niu, S.C. Chen, D.J. Manfra, M.T. Wiekowski, L.M. Sullivan, S.R. Smith, H.B. Greenberg, S.K. Narula, M. Lipp, and S.A. Lira. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12:495-503.
71. Stumbles, P.A., D.H. Strickland, C.L. Pimm, S.F. Proksch, A.M. Marsh, A.S. McWilliam, A. Bosco, I. Tobagus, J.A. Thomas, S. Napoli, A.E.I. Proudfoot, T.N.C. Wells, and P.G. Holt. 2001. Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus. J. Immunol. 167:228-234.
72. Del Prete, A., W. Vermi, E. Dander, K. Otero, L. Barberis, W. Luini, S. Bernasconi, M. Sironi, A. Santoni, C. Garlanda, F. Facchetti, M.P. Wymann, A. Vecchi, E. Hirsch, A. Mantovani, and S. Sozzani. 2004. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J. 23:3505-3515.
73. Shreedhar, V., A.M. Moodycliffe, S.E. Ullrich, C. Bucana, M.L. Kripke, and L. Flores-Romo. 1999. Dendritic cells require T cells for functional maturation in vivo. Immunity 11:625-636.
74. Borkowski, T.A., J.J. Letterio, A.G. Farr, and M.C. Udey. 1996. A role for endogenous transforming growth factor b1 in Langerhans cell biology: The skin of transforming growth factor b1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184:2417-2422.
75. Hacker, C., R.D. Kirsch, X.S. Ju, T. Hieronymus, T.C. Gust, C. Kuhl, T. Jorgas, S.M. Kurz, S. Rose-John, Y. Yokota, and M. Zenke. 2003. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4:380-386.
76. Borkowski, T.A., J.J. Letterio, C.L. Mackall, A. Saitoh, X.J. Wang, D.R. Roop, R.E. Gress, and M.C. Udey. 1997. A role for TGF?1 in Langerhans cell biology-Further characterization of the epidermal Langerhans cell defect in TGFb1 null mice. J. Clin. Invest. 100:575-581.
77. Picker, L.J., J.R. Treer, B. Ferguson-Darnell, P.A. Collins, P.R. Bergstresser, and L.W.M.M. Terstappen. 1993. Control of lymphocyte recirculation in man: II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J. Immunol. 150:1122-1136.
78. Strunk, D., C. Egger, G. Leitner, D. Hanau, and G. Stingl. 1997. A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood. J. Exp. Med. 185:1131-1136.
79. Koszik, F., D. Strunk, I. Simonitsch, L.J. Picker, G. Stingl, and E. Payer. 1994. Expression of monoclonal antibody HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin. J. Invest. Dermatol. 102:773-780.
80. Ratzinger, G., P. Stoitzner, S. Ebner, M.B. Lutz, G.T. Layton, C. Rainer, R.M. Senior, J.M. Shipley, P. Fritsch, G. Schuler, and N. Romani. 2002. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168:4361-4371.
81. Cumberbatch, M., R.J. Dearman, C.E.M. Griffiths, and I. Kimber. 2003. Epidermal Langerhans cell migration and sensitisation to chemical allergens. APMIS 111:797-804.
82. Stumbles, P.A., J.W. Upham, and P.G. Holt. 2003. Airway dendritic cells: co-ordinators of immunological homeostasis and immunity in the respiratory tract. APMIS 111:741-755.
83. Legge, K.L. and T.J. Braciale. 2003. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18:265-277.
84. Vermaelen, K.Y., D. Cataldo, K. Tournoy, T. Maes, A. Dhulst, R. Louis, J.M. Foidart, A. Noël, and R. Pauwels. 2003. Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J. Immunol. 171:1016-1022.
85. Dekaris, I., S.N. Zhu, and M.R. Dana. 1999. TNF-a regulates corneal Langerhans cell migration. J. Immunol. 162:4235-4239.
86. Tang, A., M. Amagai, L.G. Granger, J.R. Stanley, and M.C. Udey. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by Ecadherin. Nature 361:82-85.
87. Schwarzenberger, K. and M.C. Udey. 1996. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106:553-558.
88. Moodycliffe, A.M., V. Shreedhar, S.E. Ullrich, J. Walterscheid, C. Bucana, M.L. Kripke, and L. Flores-Romo. 2000. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J. Exp. Med. 191:2011-2020.
89. Jolles, S., J. Christensen, M. Holman, G.B. Klaus, and A. Ager. 2002. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin. Clin. Exp. Immunol. 129:519-526.
90. Mehling, A., K. Loser, G. Varga, D. Metze, T.A. Luger, T. Schwarz, S. Grabbe, and S. Beissert. 2001. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194:615-628.
91. Ichiyasu, H., J.M. McCormack, K.M. McCarthy, D. Dombkowski, F.I. Preffer, and E.E. Schneeberger. 2004. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am. J. Respir. Cell Mol. Biol. 30:761-770.
92. Caux, C., S. Ait-Yahia, K. Chemin, O. de Bouteiller, M.C. Dieu-Nosjean, B. Homey, C. Massacrier, B. Vanbervliet, A. Zlotnik, and A. Vicari. 2000. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22:345-369.
93. Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kiafard, J. Zwirner, T. Blankenstein, G. Henning, and R. Förster. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21:279-288.
94. Kobayashi, Y., M.-J. Staquet, C. Dezutter-Dambuyant, and D. Schmitt. 1994. Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. Eur. J. Immunol. 24:2254-2257.
95. Luther, S.A., H.L. Tang, P.L. Hyman, A.G. Farr, and J.G. Cyster. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. U. S. A. 97:12694-12699.
96. Zaitseva, M., A. Blauvelt, S. Lee, C.K. Lapham, V. Klaus-Kovtun, H. Mostowski, J. Manischewitz, and H. Golding. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 3:1369-1375.
97. Sato, N., S.K. Ahuja, M. Quinones, V. Kostecki, R.L. Reddick, P.C. Melby, W.A. Kuziel, and S.S. Ahuja. 2000. CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192:205-218.
98. Weiss, J.M., A.C. Renkl, C.S. Maier, M. Kimmig, L. Liaw, T. Ahrens, S. Kon, M. Maeda, H. Hotta, T. Uede, and J.C. Simon. 2001. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194:1219-1229.
99. Randolph, G.J., S. Beaulieu, M. Pope, I. Sugawara, L. Hoffman, R.M. Steinman, and W.A. Muller. 1998. A physiologic function for pglycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. U. S. A. 95:6924-6929.
100. Gunn, M.D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L.T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-460.
101. Robbiani, D.F., R.A. Finch, D. Jäger, W.A. Muller, A.C. Sartorelli, and G.J. Randolph. 2000. The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3b, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757-768.
102. Wei, S.H., I. Parker, M.J. Miller, and M.D. Cahalan. 2004. A stochastic view of lymphocyte motility and trafficking within the lymph node. Immunol. Rev. 195:136-159.
103. Price, A.A., M. Cumberbatch, I. Kimber, and A. Ager. 1997. a6 Integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186:1725-1735.
104. Grabbe, S., G. Varga, S. Beissert, M. Steinert, G. Pendl, S. Seeliger, W. Bloch, T. Peters, T. Schwarz, C. Sunderkötter, and K. Scharffetter-Kochanek. 2002. Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J. Clin. Invest. 109:183-192.
105. Xu, H., H.B. Guan, G.R. Zu, D. Bullard, J. Hanson, M. Slater, and C.A. Elmets. 2001. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur. J. Immunol. 31:3085-3093.
106. Weiss, J.M., J. Sleeman, A.C. Renkl, H. Dittmar, C.C. Termeer, S. Taxis, N. Howells, M. Hofmann, G. Köhler, E. Schöpf, H. Ponta, P. Herrlich, and J.C. Simon. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1137-1147.
107. Mummert, M.E., M. Mohamadzadeh, D.I. Mummert, N. Mizumoto, and A. Takashima. 2000. Development of a peptide inhibitor of hyaluronanmediated leukocyte trafficking. J. Exp. Med. 192:769-779.
108. Basbaum, C.B. and Z. Werb. 1996. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8:731-738.
109. Kobayashi, Y., M. Matsumoto, M. Kotani, and T. Makino. 1999. Possible involvement of matrix metalloproteinase-9 in langerhans cell migration and maturation. J. Immunol. 163:5989-5993.
110. Lebre, M.C., P. Kalinski, P.K. Das, and V. Everts. 1999. Inhibition of contact sensitizer-induced migration of human Langerhans cells by matrix metalloproteinase inhibitors. Arch. Dermatol. Res. 291:447-452.
111. Heffler, L.C., A.L. Kastman, G.J. Ekman, A. Scheynius, and J. Fransson. 2002. Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata. Br. J. Dermatol. 147:222-229.
112. Staquet, M.J., N. Piccardi, A. Piccirilli, C. Vincent, D. Schmitt, and P. Msika. 2004. Novel protein kinase C and matrix metalloproteinase inhibitors of vegetable origin as potential modulators of Langerhans cell migration following hapteninduced sensitization. Int. Arch. Allergy Immunol. 133:348-356.
113. Cumberbatch, M., R.J. Dearman, and I. Kimber. 1997. Langerhans cells require signals from both tumour necrosis factor-a and interleukin-1b for migration. Immunology 92:388-395.
114. Stoitzner, P., M. Zanella, U. Ortner, M. Lukas, A. Tagwerker, K. Janke, M.B. Lutz, G. Schuler, B. Echtenacher, B. Ryffel, F. Koch, and N. Romani. 1999. Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-a and IL-1b. J. Leukoc. Biol. 66:462-470.
115. Zhang, Y.H., K. McCluskey, K. Fujii, and L.M. Wahl. 1998. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-a granulocytemacrophage CSF, and IL-1b through prostaglandin-dependent and-independent mechanisms. J. Immunol. 161:3071-3076.
116. Murphy, G. and J. Gavrilovic. 1999. Proteolysis and cell migration: creating a path? Curr. Opin. Cell Biol. 11:614-621.
117. Angeli, V., H. Hammad, B. Staels, M. Capron, B.N. Lambrecht, and F. Trottein. 2003. Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response. J. Immunol. 170:5295-5301.
118. Angeli, V., C. Faveeuw, O. Roye, J. Fontaine, E. Teissier, A. Capron, I. Wolowczuk, M. Capron, and F. Trottein. 2001. Role of the parasitederived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193:1135-1147.
119. Saeki, H., A.M. Moore, M.J. Brown, and S.T. Hwang. 1999. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162:2472-2475.
120. Martín-Fontecha, A., S. Sebastiani, U.E. Höpken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615-621.
121. Kellermann, S.A., S. Hudak, E.R. Oldham, Y.J. Liu, and L.M. McEvoy. 1999. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3b are potent chemoattractants for in vitro-and in vivo-derived dendritic cells. J. Immunol. 162:3859-3864.
122. Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33.
123. Scandella, E., Y. Men, S. Gillessen, R. Förster, and M. Groettrup. 2002. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100:1354-1361.
124. Luft, T., M. Jefford, P. Luetjens, T. Toy, H. Hochrein, K.A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky. 2002. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood 100:1362-1372.
125. Kabashima, K., D. Sakata, M. Nagamachi, Y. Miyachi, K. Inaba, and S. Narumiya. 2003. Prostaglandin E(2)-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9:744-749.
126. Bouchon, A., C. Hernández-Munain, M. Cella, and M. Colonna. 2001. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:1111-1122.
127. Schiavoni, G., F. Mattei, P. Borghi, P. Sestili, M. Venditti, H.C. Morse, III, F. Belardelli, and L. Gabriele. 2004. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 103:2221-2228.
128. Luft, T., E. Maraskovsky, M. Schnurr, K. Knebel, M. Kirsch, M. Gorner, R. Skoda, A.D. Ho, P. Nawroth, and A. Bierhaus. 2004. Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 104:1066-1074.
129. Ngo, V.N., H.L. Tang, and J.G. Cyster. 1998. Epstein-Barr virusinduced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med. 188:181-191.
130. Dieu-Nosjean, M.C., A. Vicari, S. Lebecque, and C. Caux. 1999. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J. Leukoc. Biol. 66:252-262.
131. Miyasaka, M. and T. Tanaka. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4:360-370.
132. Sixt, M., R. Förster, K. Scharffetter-Kochanek, L. Sorokin, and M.B. Lutz. 2003. Requirements for dendritic cell migration inside the lymph node. European Network of Immunology Institutes Conference. Submitted.
133. Maestroni, G.J.M. 2000. Dendritic cell migration controlled by a1badrenergic receptors. J. Immunol. 165:6743-6747.
134. Idzko, M., A. La Sala, D. Ferrari, E. Panther, Y. Herouy, S. Dichmann, M. Mockenhaupt, F. Di Virgilio, G. Girolomoni, and J. Norgauer. 2002. Expression and function of histamine receptors in human monocyte-derived dendritic cells. J. Allergy Clin. Immunol. 109:839-846.
135. Schnurr, M., T. Toy, P. Stoitzner, P. Cameron, A. Shin, T. Beecroft, I.D. Davis, J. Cebon, and E. Maraskovsky. 2003. ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 102:613-620.
136. Hofer, S., L. Ivarsson, P. Stoitzner, M. Auffinger, C. Rainer, N. Romani, and C. Heufler. 2004. Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J. Invest. Dermatol. 121:300-307.
137. Katagiri, K., N. Ohnishi, K. Kabashima, T. Iyoda, N. Takeda, Y. Shinkai, K. Inaba, and T. Kinashi. 2004. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat. Immunol. 5:1045-1051.
138. Fukunaga, A., H. Nagai, T. Noguchi, H. Okazawa, T. Matozaki, X.J. Yu, C.F. Lagenaur, N. Honma, M. Ichihashi, M. Kasuga, C. Nishigori, and T. Horikawa. 2004. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes. J. Immunol. 172:4091-4099.
139. Kopp, E. and R. Medzhitov. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15:396-401.
140. Geissmann, F., M.C. Dieu-Nosjean, C. Dezutter, J. Valladeau, S. Kayal, M. Leborgne, N. Brousse, S. Saeland, and J. Davoust. 2002. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196:417-430.
141. Randolph, G.J. 2002. Commentary-Is maturation required for Langerhans cell migration? J. Exp. Med. 196:413-416.
142. Stoitzner, P., C.H. Tripp, P. Douillard, S. Saeland, and N. Romani. 2005. Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J. Invest. Dermatol. In press.
143. Zou, W.P., V. Machelon, A. Coulomb-L'Hermin, J. Borvak, F. Nome, T. Isaeva, S. Wei, R. Krzysiek, I. Durand-Gasselin, A. Gordon, T. Pustilnik, D.T. Curiel, P. Galanaud, F. Capron, D. Emilie, and T.J. Curiel. 2001. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 7:1339-1346.
144. Penna, G., S. Sozzani, and L. Adorini. 2001. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167:1862-1866.
145. Penna, G., M. Vulcano, S. Sozzani, and L. Adorini. 2002. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 63:1164-1171.
146. Bangert, C., J. Friedl, G. Stary, G. Stingl, and T. Kopp. 2003. Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? J. Invest. Dermatol. 121:1409-1418.
147. Yoneyama, H., K. Matsuno, Y. Zhang, T. Nishiwaki, M. Kitabatake, S. Ueha, S. Narumi, S. Morikawa, T. Ezaki, B. Lu, C. Gerard, S. Ishikawa, and K. Matsushima. 2004. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 16:915-928.
148. Steinman, R.M. and M.D. Witmer. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. U. S. A. 75:5132-5136.
149. Stingl, G., S.I. Katz, L. Clements, I. Green, and E.M. Shevach. 1978. Immunologic functions of Ia-bearing epidermal Langerhans cells. J. Immunol. 121:2005-2013.
150. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J.P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361-367.
151. Wu, S.J.L., G. Grouard-Vogel, W. Sun, J.R. Mascola, E. Brachtel, R. Putvatana, M.K. Louder, L. Filgueira, M.A. Marovich, H.K. Wong, A. Blauvelt, G.S. Murphy, M.L. Robb, B.L. Innes, D.L. Birx, C.G. Hayes, and S.S. Frankel. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.
152. Moll, H., H. Fuchs, C. Blank, and M. Röllinghoff. 1993. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23:1595-1601.
153. Bozza, S., R. Gaziano, A. Spreca, A. Bacci, C. Montagnoli, P. Di Francesco, and L. Romani. 2002. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J. Immunol. 168:1362-1371.
154. Ato, M., S. Stager, C.R. Engwerda, and P.M. Kaye. 2002. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat. Immunol. 3:1185-1191.
155. Bell, D., P. Chomarat, D. Broyles, G. Netto, G.M. Harb, S. Lebecque, J. Valladeau, J. Davoust, K.A. Palucka, and J. Banchereau. 1999. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 190:1417-1425.
156. Salio, M., M. Cella, W. Vermi, F. Facchetti, M.J. Palmowski, C.L. Smith, D. Shepherd, M. Colonna, and V. Cerundolo. 2003. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanomaspecific CD8 lymphocytes and are found in primary melanoma lesions. Eur. J. Immunol. 33:1052-1062.
157. Vicari, A.P., C. Chiodoni, C. Vaure, S. Ait-Yahia, C. Dercamp, F. Matsos, O. Reynard, C. Taverne, P. Merle, M.P. Colombo, A. O'Garra, G. Trinchieri, and C. Caux. 2002. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and antiinterleukin 10 receptor antibody. J. Exp. Med. 196:541-549.
158. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
159. Steinman, R.M. and M.C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U. S. A. 99:351-358.
160. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779.
161. Wolff, K. 1967. The Langerhans cells. Results of newer experimental studies. I. Arch. Klin. Exp. Dermatol. 229:54-75.
162. Nakagawa, H., Y. Hori, S. Sato, T.B. Fitzpatrick, and R.L. Martuza. 1984. The nature and origin of the melanin macroglobule. J. Invest. Dermatol. 83:134-139.
163. Parr, M.B., L. Kepple, and E.L. Parr. 1991. Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle. Biol. Reprod. 45:252-260.
164. Akbari, O., R.H. DeKruyff, and D.T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725-731.
165. Menges, M., S. Rössner, C. Voigtländer, H. Schindler, N.A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, and M.B. Lutz. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor a induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:15-21.
166. Belz, G.T., G.M.N. Behrens, C.M. Smith, J.F.A.P. Miller, C. Jones, K. Lejon, C.G. Fathman, S.N. Mueller, K. Shortman, F.R. Carbone, and W.R. Heath. 2002. The CD8?{thorn} dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196:1099-1104.
167. Mayerova, D., E.A. Parke, L.S. Bursch, O.A. Odumade, and K.A. Hogquist. 2004. Langerhans cells activate naïve self-antigen specific CD8 T cells in the steady state. Immunity 21:391-400.
168. Shibaki, A., A. Sato, J.C. Vogel, F. Miyagawa, and S.I. Katz. 2004. Induction of GVHD-like skin disease by passively transferred T cell receptor transgenic CD8{thorn} T cells into keratin-14-ovalbumin transgenic mice. J. Invest. Dermatol. 123:109-115.
169. Schuler, G., B. Schuler-Thurner, and R.M. Steinman. 2003. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15:138-147.
170. Cerundolo, V., I.F. Hermans, and M. Salio. 2004. Dendritic cells: a journey from laboratory to clinic. Nat. Immunol. 5:7-10.
171. Gilboa, E. 2004. The promise of cancer vaccines. Nat. Rev. Cancer 4:401-411.
172. Figdor, C.G., I.J. de Vries, W.J. Lesterhuis, and C.J. Melief. 2004. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10:475-480.
173. Nair, S., C. McLaughlin, A. Weizer, Z. Su, D. Boczkowski, J. Dannull, J. Vieweg, and E. Gilboa. 2003. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 171:6275-6282.
174. Blocklet, D., M. Toungouz, R. Kiss, M. Lambermont, T. Velu, D. Duriau, M. Goldman, and S. Goldman. 2003. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur. J. Nucl. Med. 30:440-447.
175. De Vries, I.J.M., D.J.E.B. Krooshoop, N.M. Scharenborg, W.J. Lesterhuis, J.H.S. Diepstra, G.N.P. Van Muijen, S.P. Strijk, T.J. Ruers, O.C. Boerman, W.J.G. Oyen, G.J. Adema, C.J.A. Punt, and C.G. Figdor. 2003. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63:12-17.
176. Morse, M.A., R.E. Coleman, G. Akabani, N. Niehaus, D. Coleman, and H.K. Lyerly. 1999. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59:56-58.
177. Jonuleit, H., A. Giesecke-Tuettenberg, T. Tüting, B. Thurner-Schuler, T.B. Stuge, L. Paragnik, A. Kandemir, P.P. Lee, G. Schuler, J. Knop, and A.H. Enk. 2001. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 93:243-251.
178. Josien, R., H.L. Li, E. Ingulli, S. Sarma, B.R. Wong, M. Vologodskaia, R.M. Steinman, and Y. Choi. 2000. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 191:495-501.